Targeted Blood Cancer Therapies Offer Significant Improvements in Survival #ASH15

da Salute H24 — 9 dicembre 2015 alle 7:14

New, highly targeted treatment approaches for leukemia, lymphoma, and myeloma to be presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition represent a tremendous expansion of oral and intravenous therapy options for patients with blood cancers. 

The treatment landscape for hematologic malignancies is evolving rapidly, as recent insights into the genetic… Continua »


Scrivi un commento